Onychomycosis refers to a fungal infection that causes discoloration, thickening, and separation of the nails. It can be treated through medications, laser therapy, and photodynamic therapies. Its treatment is usually given based on the type of fungus causing infection, the number of affected nails, and the severity of nail involvement.

Global Onychomycosis Treatment Market Trends:

Onychomycosis is a common nail disorder among senior citizens and athletes caused by organisms, such as dermatophytes, non-dermatophyte molds, and yeasts. This, in confluence with the rising geriatric population, which is highly prone to circulatory disorders and weakened immune system, is strengthening the market growth. Besides this, the increasing number of individuals who use occlusive footwear, shared bathing facilities, and public swimming pools is augmenting the risk of developing onychomycosis and catalyzing the demand for enhanced onychomycosis treatment. In addition to this, the development of water-soluble anti-fungal treatment solutions that can be administered orally is propelling the market growth.

Request Free Sample Report: https://www.imarcgroup.com/onychomycosis-treatment-market/requestsample

Global Onychomycosis Treatment Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

Bausch Health Companies Inc., Cipla Limited, Dr. Reddy's Laboratories, Galderma SA, GlaxoSmithKline PLC, Kaken Pharmaceutical Co. Ltd, Lumenis Ltd, Moberg Pharma AB, Novartis AG, Pfizer Inc. and The OTC Lab B.V.

Breakup by Disease Type:

Distal Subungual Onychomycosis

Proximal Subungual Onychomycosis

White Superficial Onychomycosis

Candidal Onychomycosis

Others

Breakup by Treatment Type:

Laser Therapy

Photodynamic Therapy

Drug Treatment

Breakup by Drug Class:

Allylamine

Azole

Griseofulvin

Others

Breakup by Distribution Channel:

Hospitals and Clinics

Online Stores

Retail Pharmacies

Others

Breakup by Region:

North America:( United States, Canada)

Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)

Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

Latin America: (Brazil, Mexico, Others)

Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/onychomycosis-treatment-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.